Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021
Authors:
Open Access
- 16 November 2022
- journal article
- research article
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (12) , e1807-e1814
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention
- World Health Organization
- Rotary Foundation
This publication has 24 references indexed in Scilit:
- Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trialVaccine, 2015
- Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgameExpert Review of Vaccines, 2015
- Prevalence of Asymptomatic Poliovirus Infection in Older Children and Adults in Northern India: Analysis of Contact and Enhanced Community Surveillance, 2009The Journal of Infectious Diseases, 2014
- Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysisThe Journal of Infectious Diseases, 2014
- Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern NigeriaJournal of Virology, 2013
- Priming after a Fractional Dose of Inactivated Poliovirus VaccineNew England Journal of Medicine, 2013
- Bivariate random effects models for meta-analysis of comparative studies with binary outcomes: Methods for the absolute risk difference and relative riskStatistical Methods in Medical Research, 2010
- Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradicationVaccine, 2009
- VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATIONAnnual Review of Microbiology, 2005
- Factors Affecting the Immunogenicity of Oral Poliovirus Vaccine in Developing Countries: ReviewClinical Infectious Diseases, 1991